Central serous chorioretinopathy after bone marrow transplantation

Amani A. Fawzi*, Emmett T. Cunningham

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

38 Scopus citations


PURPOSE: To describe central serous chorioretinopathy after bone marrow transplantation. METHODS: The medical records of the patient were reviewed retrospectively. RESULTS: A 46-year-old Filipino man developed multifocal central serous chorioretinopathy affecting his left eye 4 months after bone marrow transplantation for acute myelogenous leukemia. Other co-existing medical problems at the time of presentation included systemic hypertension and graft-versus-host-disease (GVHD), for which the patient was using both systemic corticosteroids and cyclosporine. CONCLUSION: Central serous chorioretinopathy is a rare cause of vision loss in patients after bone marrow transplantation. Previous descriptions of bone marrow transplantation-associated central serous chorioretinopathy in patients with thrombotic microangiopathy, as well as the occurrence of both systemic hypertension and the use of systemic corticosteroids and cyclosporine in our patient with bone marrow transplantation-associated central serous chorioretinopathy, support theories of choroidal vascular compromise in the pathogenesis of central serous chorioretinopathy.

Original languageEnglish (US)
Pages (from-to)804-805
Number of pages2
JournalAmerican journal of ophthalmology
Issue number6
StatePublished - 2001

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Central serous chorioretinopathy after bone marrow transplantation'. Together they form a unique fingerprint.

Cite this